Vita, Fabio
Gualtierotti, Roberta http://orcid.org/0000-0001-6465-7624
Miceli, Marco
Tedeschi, Roberto
Origlio, Flavio
Cavallo, Marco
Galletti, Stefano
Stella, Salvatore Massimo
Guerra, Enrico
Donati, Danilo
Faldini, Cesare
Clinical trials referenced in this document:
Documents that mention this clinical trial
Fibro-adhesive Bursitis: A Novel Sonographic Finding in Adhesive Capsulitis Patients and a Proposal of Management
https://doi.org/10.1007/s40744-024-00716-8
Funding for this research was provided by:
Ministero della Salute (Ricerca Corrente)
Article History
Received: 28 June 2024
Accepted: 16 August 2024
First Online: 12 September 2024
Declarations
:
: Roberta Gualtierotti is advisory board of Bayer, Roche, Sanofi, SOBI, Novo Nordisk; and speaker bureau/educational meetings Pfizer, SOBI, Takeda, Novo Nordisk. Fabio Vita, Marco Miceli, Roberto Tedeschi, Flavio Origlio, Marco Cavallo, Stefano Galletti, Salvatore Massimo Stella, Enrico Guerra, Danilo Donati and Cesare Faldini have nothing to disclose.
: The study protocol was rigorously reviewed and approved by the local Ethics Committee (379/2022/Sper/IOR) of IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, ensuring compliance with the ethical standards stipulated in the Declaration of Helsinki. Comprehensive informed consent was obtained from all participants, which covered all aspects of the intervention, potential risks, benefits, and the use of photographic or video documentation for research purposes.